Prof. Naim Shehadeh, Israel

Director, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel
Presedent of the Israel Diabetes Association 
Clinical Associate Professor, Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel


1. Gastrointestinal tract as a target organ of oral insulin: studies on the effect of orally administered insulin on the maturation of the GI tract.
2. Development of new infant formulas enriched with insulin for better maturation of gastrointestinal system in premature infants. A new infant formula was developed, and human clinical trial trials are being carried out. Phase 1 and phase 2 trials were completed successfully, and in August 2016, phase 3 studies commenced in Europe and the USA. More than $42 million were raised as investments during the years 2014-2016.
3. Metabolic control of diabetic patients.
4. Prevention of acute and chronic diabetes complications. Development of a unique optic filter for the prevention of diabetic retnopathy.